Carolinas Wealth Consulting’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,070
Closed -$15.9K 650
2025
Q1
$15.9K Hold
1,070
﹤0.01% 475
2024
Q4
$16K Hold
1,070
﹤0.01% 492
2024
Q3
$20.5K Buy
1,070
+20
+2% +$415 ﹤0.01% 476
2024
Q2
$21.7K Hold
1,050
﹤0.01% 469
2024
Q1
$19.7K Buy
1,050
+484
+86% +$8.31K ﹤0.01% 484
2023
Q4
$794 Hold
566
﹤0.01% 856
2023
Q3
$803 Sell
566
-157
-22% -$3.27K ﹤0.01% 869
2023
Q2
$4.17K Sell
723
-1
-0.1% -$22 ﹤0.01% 696
2023
Q1
$4.67K Hold
724
﹤0.01% 693
2022
Q4
$5.44K Sell
724
-6
-0.8% -$153 ﹤0.01% 681
2022
Q3
$5K Sell
730
-34
-4% -$1.03K ﹤0.01% 660
2022
Q2
$8K Buy
764
+549
+255% +$19.2K ﹤0.01% 606
2022
Q1
$8K Sell
215
-29
-12% -$992 ﹤0.01% 646
2021
Q4
$7K Sell
244
-104
-30% -$3.39K ﹤0.01% 665
2021
Q3
$11K Sell
348
-110
-24% -$3.52K ﹤0.01% 571
2021
Q2
$14K Buy
+458
New +$15.1K ﹤0.01% 567

Other funds holding OGN

Carolinas Wealth Consulting's OGN Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 1,070 shares — an estimated $15.9K sold.

Carolinas Wealth Consulting first reported a position in OGN in Q2 2021 and held it in 16 quarters. The position peaked at $21.7K in Q2 2024. 694 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 1,070 Organon & Co shares in Q2 2025, an estimated $15.9K.
  • Carolinas Wealth Consulting first reported a position in Organon & Co in Q2 2021 and held it in 16 quarters.
  • Carolinas Wealth Consulting's Organon & Co position peaked at $21.7K in Q2 2024.
  • 694 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.